Keith Sultan

TL;DR: The preliminary data support the utility of circulating plasma miRNAs to distinguish women with ovarian cancer from those with a benign mass and identify women likely to benefit from currently available treatment for serous epithelial ovarian cancerFrom those who may not.

TL;DR: In this large real‐world cohort, VDZ was well tolerated and effective in achieving key clinical outcomes and prior exposure to a TNF&agr; antagonist was associated with a reduced probability of achieving clinical remission.

TL;DR: In patients with IBD and a history of cancer, exposure to an anti-TNF agent or an antimetabolite after cancer was not associated with an increased risk of incident cancer, compared with patients who did not receive immunosuppression.

TL;DR: A scoring system to identify patients with Crohn's disease who respond to vedolizumab has been created and validated and is needed to optimize its accuracy in select populations and determine its cost-effectiveness.

TL;DR: Dysbiosis has been shown to lower circulating lymphocytes, and increase neutrophil to lymphocyte ratio, a finding which has been associated with a decreased survival in women with breast cancers, and a better understanding of dietary factors and how they disrupt the microbiome may lead to beneficial nutritional interventions for breast cancer patients.